Literature DB >> 29470967

A Spotlight on Appetite.

Lisa R Beutler1, Zachary A Knight2.   

Abstract

Remarkably few hormones have been identified that stimulate appetite. The recent discovery of asprosin, a hormone that activates AgRP neurons to increase food intake and body weight, begins to fill this gap (Duerrschmid et al., 2017; Romere et al., 2016).
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29470967      PMCID： PMC5965268          DOI： 10.1016/j.neuron.2018.01.050

Source DB:  PubMed          Journal:  Neuron        ISSN： 0896-6273            Impact factor:   17.173


  10 in total

1.  NPY/AgRP neurons are essential for feeding in adult mice but can be ablated in neonates.

Authors:  Serge Luquet; Francisco A Perez; Thomas S Hnasko; Richard D Palmiter
Journal:  Science       Date:  2005-10-28       Impact factor: 47.728

2.  Neonatal progeroid variant of Marfan syndrome with congenital lipodystrophy results from mutations at the 3' end of FBN1 gene.

Authors:  Adeline Jacquinet; Alain Verloes; Bert Callewaert; Christine Coremans; Paul Coucke; Anne de Paepe; Uwe Kornak; Frederic Lebrun; Jacques Lombet; Gérald E Piérard; Peter N Robinson; Sofie Symoens; Lionel Van Maldergem; François-Guillaume Debray
Journal:  Eur J Med Genet       Date:  2014-03-06       Impact factor: 2.708

3.  Asprosin, a Fasting-Induced Glucogenic Protein Hormone.

Authors:  Chase Romere; Clemens Duerrschmid; Juan Bournat; Petra Constable; Mahim Jain; Fan Xia; Pradip K Saha; Maria Del Solar; Bokai Zhu; Brian York; Poonam Sarkar; David A Rendon; M Waleed Gaber; Scott A LeMaire; Joseph S Coselli; Dianna M Milewicz; V Reid Sutton; Nancy F Butte; David D Moore; Atul R Chopra
Journal:  Cell       Date:  2016-04-14       Impact factor: 41.582

Review 4.  Ghrelin as a Survival Hormone.

Authors:  Bharath K Mani; Jeffrey M Zigman
Journal:  Trends Endocrinol Metab       Date:  2017-10-30       Impact factor: 12.015

Review 5.  Congenital generalized lipodystrophies--new insights into metabolic dysfunction.

Authors:  Nivedita Patni; Abhimanyu Garg
Journal:  Nat Rev Endocrinol       Date:  2015-08-04       Impact factor: 43.330

6.  Induced ablation of ghrelin cells in adult mice does not decrease food intake, body weight, or response to high-fat diet.

Authors:  Matthew R McFarlane; Michael S Brown; Joseph L Goldstein; Tong-Jin Zhao
Journal:  Cell Metab       Date:  2014-05-15       Impact factor: 27.287

Review 7.  20 years of leptin: human disorders of leptin action.

Authors:  I Sadaf Farooqi; Stephen O'Rahilly
Journal:  J Endocrinol       Date:  2014-10       Impact factor: 4.286

8.  Reduced body weight is a common effect of gene knockout in mice.

Authors:  Danielle R Reed; Maureen P Lawler; Michael G Tordoff
Journal:  BMC Genet       Date:  2008-01-08       Impact factor: 2.797

9.  Gs-coupled GPCR signalling in AgRP neurons triggers sustained increase in food intake.

Authors:  Ken-ichiro Nakajima; Zhenzhong Cui; Chia Li; Jaroslawna Meister; Yinghong Cui; Ou Fu; Adam S Smith; Shalini Jain; Bradford B Lowell; Michael J Krashes; Jürgen Wess
Journal:  Nat Commun       Date:  2016-01-08       Impact factor: 14.919

10.  Asprosin is a centrally acting orexigenic hormone.

Authors:  Clemens Duerrschmid; Yanlin He; Chunmei Wang; Chia Li; Juan C Bournat; Chase Romere; Pradip K Saha; Mark E Lee; Kevin J Phillips; Mahim Jain; Peilin Jia; Zhongming Zhao; Monica Farias; Qi Wu; Dianna M Milewicz; V Reid Sutton; David D Moore; Nancy F Butte; Michael J Krashes; Yong Xu; Atul R Chopra
Journal:  Nat Med       Date:  2017-11-06       Impact factor: 53.440
  10 in total
  6 in total

1.  Increased plasma asprosin levels in patients with drug-naive anorexia nervosa.

Authors:  Yanran Hu; Yixiang Xu; Yuchen Zheng; Qing Kang; Zhongze Lou; Qiang Liu; Han Chen; Yunxin Ji; Lei Guo; Chen Chen; Liemin Ruan; Jue Chen
Journal:  Eat Weight Disord       Date:  2020-02-05       Impact factor: 4.652

2.  Serum Asprosin Concentrations in Children with Prader-Willi Syndrome: Correlations with Metabolic Parameters.

Authors:  Maha Alsaif; Catherine J Field; Eloisa Colin-Ramirez; Carla M Prado; Andrea M Haqq
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

Review 3.  Energy Regulation Mechanism and Therapeutic Potential of Asprosin.

Authors:  Jennifer G Hoffmann; Wei Xie; Atul R Chopra
Journal:  Diabetes       Date:  2020-04       Impact factor: 9.461

4.  Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature.

Authors:  Agnieszka Irena Mazur-Bialy
Journal:  Nutrients       Date:  2021-02-14       Impact factor: 5.717

5.  Apelin-13 and Asprosin in Adolescents with Anorexia Nervosa and Their Association with Psychometric and Metabolic Variables.

Authors:  Katarzyna Jowik; Monika Dmitrzak-Węglarz; Natalia Pytlińska; Anna Jasińska-Mikołajczyk; Agnieszka Słopień; Marta Tyszkiewicz-Nwafor
Journal:  Nutrients       Date:  2022-09-28       Impact factor: 6.706

6.  Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus.

Authors:  Xinyue Zhang; Hui Jiang; Xiaojing Ma; Hongyan Wu
Journal:  J Diabetes Investig       Date:  2019-10-03       Impact factor: 4.232
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.